Table 1 Demographic and clinical baseline data of the 114 patients of the main study [37] and of the subgroup of 67 women with menstrually related migraine
Main study (n = 114) | Menstruating women (n = 67) | p | |
|---|---|---|---|
Age (years, means ± SD) | 40 ± 10 | 37 ± 8 | NS |
Height (cm, means ± SD) | 165 ± 6 | 164 ± 6 | NS |
Weight (kg, means ± SD) | 65 ± 12 | 62 ± 10 | NS |
Age at onset of migraine (years, means ± SD) | 18 ± 8 | 17 ± 7 | NS |
Migraine attack duration >2 days (n, %) | 29 (25) | 16 (24) | NS |
MIDAS score (means ± SD) | 23 ± 16 | 23 ± 16 | NS |
No use of triptans in the previous 3 months (n, %) | 93 (82) | 46 (69) | <0.05 |
Moderate or severe attacks (n, %)a | 532 (80) | 133 (86) | NS |
Patients with at least one moderate or severe attack (n, %) | 111 (97) | 64 (96) | NS |